000 | 01951 a2200565 4500 | ||
---|---|---|---|
005 | 20250516072009.0 | ||
264 | 0 | _c20120320 | |
008 | 201203s 0 0 eng d | ||
022 | _a1552-6259 | ||
024 | 7 |
_a10.1016/j.athoracsur.2011.10.063 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aManne, Mahesh B | |
245 | 0 | 0 |
_aOutcomes after surgical treatment of native and prosthetic valve infective endocarditis. _h[electronic resource] |
260 |
_bThe Annals of thoracic surgery _cFeb 2012 |
||
300 |
_a489-93 p. _bdigital |
||
500 | _aPublication Type: Evaluation Study; Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAnti-Infective Agents _xtherapeutic use |
650 | 0 | 4 |
_aAortic Valve Insufficiency _xepidemiology |
650 | 0 | 4 |
_aBacteremia _xepidemiology |
650 | 0 | 4 |
_aBioprosthesis _xadverse effects |
650 | 0 | 4 | _aCombined Modality Therapy |
650 | 0 | 4 | _aComorbidity |
650 | 0 | 4 | _aDebridement |
650 | 0 | 4 |
_aEndocarditis _xdrug therapy |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 |
_aHeart Valve Prosthesis _xadverse effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aKaplan-Meier Estimate |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aMitral Valve Insufficiency _xepidemiology |
650 | 0 | 4 |
_aProsthesis-Related Infections _xdrug therapy |
650 | 0 | 4 | _aReoperation |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 |
_aSubstance Abuse, Intravenous _xcomplications |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_aTricuspid Valve Insufficiency _xepidemiology |
700 | 1 | _aShrestha, Nabin K | |
700 | 1 | _aLytle, Bruce W | |
700 | 1 | _aNowicki, Edward R | |
700 | 1 | _aBlackstone, Eugene | |
700 | 1 | _aGordon, Steven M | |
700 | 1 | _aPettersson, Gosta | |
700 | 1 | _aFraser, Thomas G | |
773 | 0 |
_tThe Annals of thoracic surgery _gvol. 93 _gno. 2 _gp. 489-93 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.athoracsur.2011.10.063 _zAvailable from publisher's website |
999 |
_c21425929 _d21425929 |